C

Covetrus Inc
F:2NJ

Watchlist Manager
Covetrus Inc
F:2NJ
Watchlist
Price: 21.52 EUR 0.19% Market Closed
Market Cap: €3B

P/B

0.1
Current
4%
More Expensive
vs 3-y average of 0.1

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
0.1
=
Market Cap
€3B
/
Total Equity
$48.1B

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
0.1
=
Market Cap
€3B
/
Total Equity
$48.1B

Valuation Scenarios

Covetrus Inc is trading above its 3-year average

If P/B returns to its 3-Year Average (0.1), the stock would be worth €20.67 (4% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-5%
Maximum Upside
+4 205%
Average Upside
1 891%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 0.1 €21.52
0%
3-Year Average 0.1 €20.67
-4%
5-Year Average 0.1 €20.45
-5%
Industry Average 3.1 €926.36
+4 205%
Country Average 2.5 €745.94
+3 366%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close

Market Distribution

Lower than 100% of companies in the United States of America
Percentile
0th
Based on 10 946 companies
0th percentile
0.1
Low
0 — 1.5
Typical Range
1.5 — 4.8
High
4.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 1.5
Median 2.5
70th Percentile 4.8
Max 147 580.5

Covetrus Inc
Glance View

Market Cap
3B EUR
Industry
Health Care

Nestled in the heart of the animal health industry, Covetrus Inc. emerged as a formidable force, blending technological expertise with deep-rooted veterinary knowledge. Created in 2019 through the merger of Henry Schein Animal Health and Vets First Choice, this company has swiftly positioned itself as an essential partner for veterinary practitioners. Covetrus provides a comprehensive suite of services designed to streamline operations for veterinary clinics, ranging from practice management software to inventory management systems. The core of their operation focuses on enhancing clinic efficiency and improving patient outcomes, driven by digital innovation that connects clinics effortlessly with critical pharmaceuticals, pet foods, and other essential products. Covetrus's business model thrives on a multi-pronged approach. Revenue streams flow widely from the robust sales of prescription and non-prescription medications, medical supplies, and pet products, underpinned by its vast, integrated distribution network. Moreover, the company's software solutions, which are integral to their service offering, generate additional income through subscription fees and service upgrades. This ability to cross-sell digital and physical products creates a cohesive ecosystem for veterinary professionals, ensuring that Covetrus not only meets day-to-day operational needs but also facilitates long-term growth and competitiveness for its customers. Their strategic positioning within the veterinary supply chain, coupled with a clear focus on enhancing clinical workflows, cements Covetrus's role as an indispensable ally in modern animal healthcare.

2NJ Intrinsic Value
Not Available
C
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett